The Lancet Gastroenterology & Hepatology is a monthly journal that considers original research, reviews, and personal views in gastroenterology and hepatology from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.
…
continue reading
Arndt Vogel (Toronto General Hospital) discusses the NALIRICC trial of nanoliposomal irinotecan added to fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies.Av The Lancet
…
continue reading
Nancy Baxter (University of Melbourne) discusses a population-based study on the duration of risk reduction in colorectal cancer incidence and mortality after a complete colonoscopy.Av The Lancet
…
continue reading
1
In conversation with... Sanna Nybacka and Magnus Simrén
23:16
23:16
Spill senere
Spill senere
Lister
Lik
Likt
23:16
Sanna Nybacka and Magnus Simrén (University of Gothenburg) discuss the CARIBS randomised controlled trial of a low FODMAP diet versus a low-carbohydrate diet versus pharmacological treatment in IBS.Av The Lancet
…
continue reading
Nuru Noor (University of Cambridge) discusses the PROFILE trial of biomarker-stratified treatment strategies in people with newly diagnosed Crohn's disease.Av The Lancet
…
continue reading
1
In conversation with... Yusuke Shimakawa
20:54
20:54
Spill senere
Spill senere
Lister
Lik
Likt
20:54
Yusuke Shimakawa (Institut Pasteur) discusses the development and evaluation of a simple score for hepatitis B treatment eligibility in Africa.Av The Lancet
…
continue reading
1
In conversation with... Mads Israelsen
16:39
16:39
Spill senere
Spill senere
Lister
Lik
Likt
16:39
Mads Israelsen (Odense University Hospital) discusses a study to validate the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake.Av The Lancet
…
continue reading
Louise Dye (University of Leeds) discusses a trial exploring the role of expectancy and gluten ingestion on symptoms in people with non-coeliac gluten sensitivity.Av The Lancet
…
continue reading
Tzu-Chan Hong (National Taiwan University Cancer Centre) discusses a systematic review and meta-analysis on primary antibiotic resistance of Helicobacter pylori between 1990 and 2022 in the Asia-Pacific region.Av The Lancet
…
continue reading
Sarah Moen (Erasmus University Medical Center) discusses a retrospective cohort study examining the risk of metachronous colorectal cancer after partial or extensive colectomy in carriers of different pathogenic Lynch syndrome variants.Av The Lancet
…
continue reading
1
In conversation with... Anna Emilie Kann
16:19
16:19
Spill senere
Spill senere
Lister
Lik
Likt
16:19
Anna Emilie Kann (Zealand University Hospital, Denmark) discusses a population-based study done in Denmark exploring the causes of mortality in patients with alcohol-related liver disease.Av The Lancet
…
continue reading
Robert Krouse (University of Pennsylvania) discusses the pragmatic S1316 trial of surgical versus non-surgical management for patients with malignant small bowel obstruction.Av The Lancet
…
continue reading
1
In conversation with... Marc Rothenberg
14:29
14:29
Spill senere
Spill senere
Lister
Lik
Likt
14:29
Marc Rothenberg (University of Cincinnati College of Medicine) discusses a new trial assessing the efficacy and safety of benralizumab in patients with eosinophilic gastritis, and how the surprising findings might change our understanding of eosinophilic gastrointestinal diseases.Av The Lancet
…
continue reading
1
In conversation with... Michael Pavlides
17:41
17:41
Spill senere
Spill senere
Lister
Lik
Likt
17:41
Michael Pavlides (University of Oxford) discusses work by the LITMUS Consortium on the prognostic performance of non-invasive tests in patients with non-alcoholic fatty liver disease.Av The Lancet
…
continue reading
1
In conversation with... Jasmohan Bajaj
12:48
12:48
Spill senere
Spill senere
Lister
Lik
Likt
12:48
Jasmohan Bajaj (Virginia Commonwealth University and Central Virginia Veterans Healthcare System, Richmond, VA, USA), on behalf of the CLEARED Consortium, discusses a prospective observational cohort study examining global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis.…
…
continue reading
1
In conversation with... Adelina Artenie
17:15
17:15
Spill senere
Spill senere
Lister
Lik
Likt
17:15
Adelina Artenie (University of Bristol, UK) discusses a systematic review and meta-analysis exploring the incidence of HIV and HCV among people who inject drugs, and associations with age and sex or gender.Av The Lancet
…
continue reading
Johan Burisch (Copenhagen University Hospital, Denmark) discusses the findings and recommendations of The Lancet Gastroenterology & Hepatology Commission on the cost of inflammatory bowel disease in high-income settings.Av The Lancet
…
continue reading
Edouard Louis (University Hospital CHU of Liège) discusses the SPARE randomised controlled trial of infliximab or concomitant immunosuppressant withdrawal in patients with Crohn’s disease.Av The Lancet
…
continue reading
Paula Ghaneh (University of Liverpool) discusses the ESPAC5 randomised controlled trial of short-course neoadjuvant therapy compared with immediate surgery for patients with borderline resectable pancreatic ductal adenocarcinoma.Av The Lancet
…
continue reading
Dan Turner (Shaare Zedek Medical Center) discusses the VEDOKIDS study on the safety, effectiveness, and dosing of vedolizumab in children with IBD.Av The Lancet
…
continue reading
1
In conversation with... Simon Baunwall
15:21
15:21
Spill senere
Spill senere
Lister
Lik
Likt
15:21
Simon Baunwall (Aarhus University Hospital) discusses the EarlyFMT trial, a randomized placebo-controlled trial of faecal microbiota transplantation for first or second Clostridioides difficile infection.Av The Lancet
…
continue reading
1
In conversation with... James Alexander
13:48
13:48
Spill senere
Spill senere
Lister
Lik
Likt
13:48
James Alexander (Imperial College London) discusses the latest findings from the VIP case-control study, which is investigating COVID-19 vaccine immune responses in immunosuppressed patients with inflammatory bowel disease.Av The Lancet
…
continue reading
1
Filip Knop on liraglutide for bile acid diarrhoea
15:02
15:02
Spill senere
Spill senere
Lister
Lik
Likt
15:02
Filip Knop (University of Copenhagen) discusses a trial of liraglutide versus colesevelam for the treatment of bile acid diarrhoea.Av The Lancet
…
continue reading
Edward Kim (Icahn School of Medicine at Mount Sinai) discusses the single-arm RASER study of radiation segmentectomy for patients with unresectable very early to early stage hepatocellular carcinoma.Av The Lancet
…
continue reading
Joep Ijspeert (Amsterdam University Medical Center) discusses a population-based study exploring the detection of proximal serrated polyps and interval post-colonoscopy colorectal cancer risk.Av The Lancet
…
continue reading
1
In conversation with... Elise Meima-van Praag
9:50
9:50
Spill senere
Spill senere
Lister
Lik
Likt
9:50
Elise Meima-van Praag (Amsterdam University Medical Centre) discusses the PISA-II trial, investigating short-term anti-TNF therapy with surgical closure versus anti-TNF therapy for perianal fistulas in Crohn's disease.Av The Lancet
…
continue reading
1
In conversation with... Juan Pablo Arab
17:06
17:06
Spill senere
Spill senere
Lister
Lik
Likt
17:06
Juan Pablo Arab (Catholic University of Chile) discusses the current burden of NAFLD and the landscape of public health policies related to the disease in the Americas.Av The Lancet
…
continue reading
Sarah Blach (CDA Foundation) summarises the latest analysis of global hepatitis C virus epidemiology and cascade of care by the Polaris Observatory HCV Collaborators.Av The Lancet
…
continue reading
Sunil Solomon (Johns Hopkins University) discusses a study of a minimal monitoring approach for treating patients with hepatitis C virus infection.Av The Lancet
…
continue reading
Rupert Leong (University of Sydney) discusses a new double-blind, randomised, placebo-controlled trial of oral faecal microbiota transplantation for patients with active ulcerative colitis.Av The Lancet
…
continue reading
Swati Patel (University of Colorado Anschutz Medical Center) discusses the epidemiology, clinical features, biology, risk factors, and opportunities for prevention and detection of early-onset colorectal cancers.Av The Lancet
…
continue reading
1
In conversation with... Emilie Breekveldt
9:39
9:39
Spill senere
Spill senere
Lister
Lik
Likt
9:39
Emilie Breekveldt (Erasmus Medical Center, Netherlands) discusses a new analysis of the faecal immunochemical testing-based colorectal screening programme in the Netherlands.Av The Lancet
…
continue reading
1
In conversation with... Wendy Spearman
22:34
22:34
Spill senere
Spill senere
Lister
Lik
Likt
22:34
Wendy Spearman (University of Cape Town) discusses a Series on the emergence of non-alcoholic fatty liver disease in Sub-Saharan Africa and the challenges it presents.Av The Lancet
…
continue reading
Tim Vanuytsel (University of Leuven) discusses a new trial of spore-forming probiotics in functional dyspepsia.Av The Lancet
…
continue reading
1
In conversation with... Raymond Henderson
11:20
11:20
Spill senere
Spill senere
Lister
Lik
Likt
11:20
Raymond Henderson (Queen’s University Belfast) discusses a new analysis of the economic burden of colorectal cancer in Europe.Av The Lancet
…
continue reading
1
In conversation with... Sigurður Ólafsson
13:09
13:09
Spill senere
Spill senere
Lister
Lik
Likt
13:09
Sigurður Ólafsson (Landspitali University Hospital) discusses newly published results from the nationwide programme to eliminate hepatitis C virus in Iceland.Av The Lancet
…
continue reading
Caroline Ovadia (King’s College London) discusses an individual participant data meta-analysis on the treatment of intrahepatic cholestasis of pregnancy with ursodeoxycholic acid.Av The Lancet
…
continue reading
Matthew Akiyama (Montefiore Medical Center and Albert Einstein College of Medicine, USA) discusses a Review on hepatitis C elimination among people incarcerated in prisons.Av The Lancet
…
continue reading
Monika Sarkar (University of California San Francisco, USA) discusses her Comment on reproductive health in women with chronic liver disease.Av The Lancet
…
continue reading
1
Colorectal cancer risk in patients with Crohn’s disease
7:04
7:04
Spill senere
Spill senere
Lister
Lik
Likt
7:04
Ola Olén discusses the assesment of colorectal cancer risk in patients with Crohn's disease.Av The Lancet
…
continue reading
1
Anti-TNFα therapy and risk of cancer in patients with immune-mediated diseases
4:08
4:08
Spill senere
Spill senere
Lister
Lik
Likt
4:08
Av The Lancet
…
continue reading
1
Eosinophilic oesophagitis endotype classification
10:17
10:17
Spill senere
Spill senere
Lister
Lik
Likt
10:17
Marc Rothenberg joins The Lancet Gastroenterology & Hepatology to talk about eosinophilic oesophagitis endotype classification.Av The Lancet
…
continue reading
Dr Kushala Abeysekara discusses research looking at the prevalence of non-alcoholic fatty liver disease in young adults in England.Av The Lancet
…
continue reading
Professor Alexander Ford discusses a meta analysis comparing different traditional treatments for irritable bowel syndrome.Av The Lancet
…
continue reading
Dr. Elisa Pose discusses the potential beneficial effects of statins on the treatment of patients with decompensated cirrhosisAv The Lancet
…
continue reading
1
Global burden of pancreatic cancer and colorectal cancer
14:44
14:44
Spill senere
Spill senere
Lister
Lik
Likt
14:44
Mohsen Naghavi describes the key findings from two new Global Burden of Disease studies investigating the global burden of pancreatic cancer and colorectal cancer.Av The Lancet
…
continue reading
Viktor Wintzell joins The Lancet Gastroenterology & Hepatology to discuss the risk of serious infection after use of tumour necrosis factor-α inhibitors in children with inflammatory bowel disease.Av The Lancet
…
continue reading
1
Transplanting hepatitis C-infected hearts
6:38
6:38
Spill senere
Spill senere
Lister
Lik
Likt
6:38
Prof Raymond Chung discusses new research in transplantation of HCV-infected hearts.Av The Lancet
…
continue reading
1
Primary anastomosis as a treatment for diverticulitis
8:29
8:29
Spill senere
Spill senere
Lister
Lik
Likt
8:29
Daniel Lambrichts joins The Lancet Gastroenterology & Hepatology to discuss different treatments for diverticulitis.Av The Lancet
…
continue reading
Dr Olga Aroniaidis discusses the results of a newly published trial of FMT to treat IBS.Av The Lancet
…
continue reading
Dr Eric Jelovsek discusses new research into the treatment of this important and often overlooked condition.Av The Lancet
…
continue reading